NON-MUSCLE-INVASIVE BLADDER CANCER
Clinical trials for NON-MUSCLE-INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE-INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for NON-MUSCLE-INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer trial tests chemo cocktail as alternative to standard therapy
Disease control OngoingThis study tests whether a combination of two chemotherapy drugs (Gemcitabine and Docetaxel) given directly into the bladder works as well as the standard BCG therapy for patients with high-grade non-muscle invasive bladder cancer who have not received BCG before. About 870 adult…
Matched conditions: NON-MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Bladder cancer drug combo shows promise in major trial
Disease control OngoingThis phase 3 study tests whether adding the immunotherapy drug durvalumab to standard BCG treatment helps people with high-risk non-muscle-invasive bladder cancer stay cancer-free longer. About 1,018 adults who have not had BCG before will be randomly assigned to receive either t…
Matched conditions: NON-MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
Simple urine test may spare bladder cancer patients from unnecessary treatments
Diagnosis OngoingThis study looks at whether a urine test measuring SIX6 gene methylation can predict if low-risk bladder cancer will come back after surgery. Researchers will compare test results from 177 patients who had a recurrence versus those who did not. If accurate, this test could help d…
Matched conditions: NON-MUSCLE-INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated May 12, 2026 13:42 UTC